Financial Times FT.com

Roche/Amgen case could signal shift in courts regarding compulsory licenses

By Marc Longpre in New York

Published: July 23 2008 06:53 | Last updated: July 23 2008 06:53

Email options

The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.Terms of use |Privacy policy

* required fields



(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)